简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2016-07-29 09:46 Growth of DCAT Week Spurs Expansion of Annual Event’s NYC Meeting Space
2016-07-28 14:01 Toyo Rice Corporation's High Priced Rice at 11,304 yen/kg Listed in Guinness World Records®*1
2016-07-25 14:55 Octapharma to Sponsor Two Symposia at the 2016 World Federation of Hemophilia (WFH) World Congress in Orlando, USA
2016-07-25 10:20 Starpharma Signs License for a VivaGel® Condom in China
2016-07-22 15:16 SES Enhances Quality of Healthcare in the Philippines Through SATMED E-Health Platform
2016-07-21 13:54 South Korea without Fail Facial Contouring Plastic Surgery Expertise
2016-07-21 11:58 Seattle Genetics and Takeda Announce Publication of Final Data from ADCETRIS® (Brentuximab Vedotin) Monotherapy Pivotal Phase 2 Clinical Trial in Relapsed or Refractory Classical Hodgkin Lymphoma in Blood
2016-07-20 16:36 The European Stroke Organisation and Boehringer Ingelheim launch the “Angels Initiative”, a unique healthcare initiative to improve acute stroke care across Europe
2016-07-18 09:54 Samsung Bioepis' Marketing Authorization Application for SB5 Adalimumab Biosimilar Candidate Accepted for Review by the European Medicines Agency
2016-07-15 10:30 Investing in Cures for Cancer: GE Poised to Lead Industrialization of Cell Therapy Industry with Acquisition of Biosafe Group SA
2016-07-14 17:32 Boehringer Ingelheim and University of Dundee collaborate to develop new class of medicines
2016-07-14 09:54 Boehringer Ingelheim and Lilly Announce Clinical Trial Collaboration in Metastatic Breast Cancer
2016-07-08 15:22 One of the World’s Leading Centers for Cardiovascular Medicine & Transplantation Adopts Masimo’s SedLine® Brain Function Monitoring and O3™ Regional Oximetry
2016-07-07 15:37 Takeda Receives European Commission Approval of ADCETRIS® (brentuximab vedotin) for Consolidation Treatment in Post-Transplant Hodgkin Lymphoma
2016-07-06 14:47 Takeda Submits a New Drug Application for Novel, Oral Proteasome Inhibitor Ixazomib in Japan
2016-07-04 17:14 Takeda to Partner with Altos Therapeutics to Develop Promising Compound for the Treatment of Gastroparesis
2016-06-30 16:26 INMARKTM now enrolling: first study to evaluate the effect of OFEV® (nintedanib) on biomarkers reflecting the underlying fibrotic process in IPF patients
2016-06-28 10:00 BioLegend Enters License Agreement with Sanquin for Peptide-MHC Assay Technology
2016-06-27 17:29 Quintiles Introduces Continuous Glucose Monitoring Services to Improve Diabetes Outcomes
2016-06-27 16:16 New analysis of INPULSIS® trials demonstrates efficacy of OFEV® (nintedanib) across a range of IPF patients using broader diagnostic criteria

Business Wire Weibo

Press Releases

Latest Releases